SECURITIES / DERIVATIVES

ESG / Sustainability

WEF Survey: Exchanges Are Deepening Climate, ESG Commitments

By Nithya Subramanian | 07/07/2025

The report outlines the increasing role played by exchanges within sustainable finance.

Securities / Derivatives

SEBI Mandates Single VWAP Contract Note for Trade Reporting

By Nithya Subramanian | 07/07/2025

The reform consolidates multi-exchange trades into a single document for institutional investors.

Securities / Derivatives

South Korea Overhauls Commercial Act to Tackle 'Korea Discount'

By Editors | 07/07/2025

The revision passed by the National Assembly expands directors' fiduciary duties and tightens voting caps for controlling shareholders.

Securities / Derivatives

Vietnam Confident of September Market Upgrade on Back of Major Reforms

By Editors | 07/07/2025

Regulators cite the new trading system and key legal amendments on foreign ownership and clearing as crucial to securing emerging market status.

Enforcement

India Bars Jane Street and Seizes $567m Over Market Manipulation Claims

By Editors | 07/07/2025

SEBI described Jane Street's trading behaviour as "egregious" and said the firm "is not a good faith actor that can be, or deserves to be, trusted."

Market Infrastructure

Chinese Exchanges to Double Price Limits for 'ST' Stocks

By Editors | 06/07/2025

The move aims to improve price discovery for risk-alerted companies and accelerate market-based delisting mechanisms.

Market Infrastructure

EU Finalises T+1 Roadmap, Highlighting Hurdles for APAC Firms

By Editors | 06/07/2025

The EU's 2027 deadline for T+1 settlement creates significant operational, FX, and funding challenges for Asia-Pacific firms and funds with Asian assets.

Securities / Derivatives

UK and Singapore Deepen Ties on Digital and Sustainable Finance

By Editors | 06/07/2025

Regulators to deepen collaboration on asset tokenisation and AI, while aligning on sustainable finance disclosures and capital market reforms.

Securities / Derivatives

Shanghai STAR Market Approves First Unprofitable IPO Under Revived Rules

By Editors | 04/07/2025

Wuhan-based drugmaker Healthgen Biotechnology got the approval, signalling renewed policy support for innovative, pre-revenue technology and life sciences firms.